← Evidence map

ArticleRisk management and healthcare policy2025

Utilization and Determinants of Anticancer Drugs Under China's National Drug Price Negotiation Policy.

Bingbing Tuo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 40689371